Ayurvedic Preventive and Curative Protocol for COVID 19 - A Proposal
Abstract
COVID-19 is an illness caused due to Novel Corona Virus 2, now called as Severe Acute Respiratory Syndrome Corona Virus -2 (SARS COV 2).[1] Ayurveda considers it as a Janapadodhwamsa Vikara.[2] It can also be grouped under the class of Bhutabhishangaja Aagantuja Vikaara with special reference Aupasargika and Sankramika disease.[3] Furthermore, Bhuta in Ayurveda also has the meaning of Visha (poison) and virus meaning in latin is poison. Here, the origin of the virus was earlier considered from animals (Bats – primary hosts, Snake - intermediate host and further Pangolins). According to Acharya Sushruta, all share the similar Yoni.[4] Considering all factors associated with Covid-19, the illness can be considered as a Sannipata Jwara with predominance of Kapha and Pitta. Interestingly the signs and symptoms seen in this condition are quite similar to the Jangama Visha Lakshana of Kitavisha originating from Yoni of Jatuka (Bat), Sarpa (Snake), Shallaka (pangolin).[6] The choice of medicine (single and poly-herbo-mineral preparations) used should be Kapha Pittahara, Tridoshahara, Rakta Prasadaka / Shodhak, Agada (Vishahara), Jwarahara, Ashukaari, Bahukalpa Rasayana / Urjaskara (drugs having immune-boosting properties) and potent antimicrobial activities. Herbo-mineral agents possessing above activities which can be used as prophylactic as well as curative measure is been proposed in the study. Considering above concepts, a detailed review is done from Ayurvedic classics and a possible frame work is proposed in regard to Samprapti (pathogenesis), prophylactic and curative aspects of COVID-19 in the study.
Downloads
References
Vagbhatta, Astanga Hrudaya, with Hemadri and Arunadutta. Sutra sthaanam, 12/66 edited by Pt. Hari Sadashiva Shastri Paradakara, Reprint ed. Chaukhambha Surabharati rakashana, Varanasi, 2007.
Agnivesha, Charaka, Dridhabala, Charaka Samhita, Vimaana Sthaanam 3/5, edited by Vaidya Jadavaji Trikamji Aacharya, Reprint ed. Chaukhambha Surabharati Prakashana, Varanasi, 2005.
Agnivesha, Charaka, Dridhabala, Charaka Samhita, Vimaana Sthaanam 3/5, edited by Vaidya Jadavaji Trikamji Aacharya, Reprint ed. Chaukhambha Surabharati Prakashana, Varanasi, 2005.
Agnivesha, Charaka, Dridhabala, Charaka Samhita, Cikitsaa Sthaanam 3/114, edited by Vaidya Jadavaji Trikamji Aacharya, Reprint ed. Chaukhambha Surabharati Prakashana, Varanasi, 2005.
Sushruta, Dalhana, Gayadasacharya, Sushruta Samhita, Nidana Sthana 5/12, edited by Vaidya Jadavaji Trikamji Aacharya, Reprint ed. Chaukhambha Surabharati Prakashana, Varanasi, 2008.
Sushruta, Dalhana, Gayadasacharya, Sushruta Samhita, Sutra Sthana 1/30, edited by Vaidya Jadavaji Trikamji Aacharya, Reprint ed. Chaukhambha Surabharati Prakashana, Varanasi, 2008.
Huang C et al, Clinical features of patients infected with 2019 novel corona virus inWuhan city, China, Lancet, January2020
www.cdc.gov/coronavirus
Sushruta, Dalhana, Gayadasacharya, Sushruta Samhita, Kalpa Sthana 8/12, edited by Vaidya Jadavaji Trikamji Aacharya, Reprint ed. Chaukhambha Surabharati Prakashana, Varanasi, 2008.
Sushruta, Dalhana, Gayadasacharya, Sushruta Samhita, Kalpa Sthana 8/19-22, edited by Vaidya Jadavaji Trikamji Aacharya, Reprint ed. Chaukhambha Surabharati Prakashana, Varanasi, 2008.
Sushruta, Dalhana, Gayadasacharya, Sushruta Samhita, Chikitsa Sthana 5/23, edited by Vaidya Jadavaji Trikamji Aacharya, Reprint ed. Chaukhambha Surabharati Prakashana, Varanasi, 2008.
Dravya Guna Vigyana; by Acharya Priyavrat Sharma, reprint ed., Chaukhambha Surabharati Academy, Varanasi, 2005.
Rajveer Sason, Anita Sharma, Neelam Arya, International Journal Of Ayurveda and Pharma Research, May2016, Vol4, Issue5, PP66.
Journal of Ayurveda and Integrated Medical Sciences (JAIMS) retains the copyright of the contents of this journal but grant the readers the right to use the contents with terms and conditions under a creative common attribution licenses 4 of Attribution, Share Alike and Non-commercial type (CC BY-NC-SA) that allows copy, distribute, display, and perform the work and make derivative works based on it only for non-commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.